SNDX logo

Syndax Pharmaceuticals, Inc. (SNDX)

Profile

Full Name

Syndax Pharmaceuticals, Inc.

Ticker

NASDAQ: SNDX

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

March 2, 2016

Indexes

Not included

Website

https://syndax.com

Employees

270

Key Details

Price

$16.37(+4.07%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$23.68M(+100.00% YoY)

Annual EPS

-$3.72(-24.83% YoY)

PE ratio

-

Next earnings date

Nov 5, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $16.37
    SNDX price is $16.37

    30-Day Relative Volume

    0.71
    SNDX 30-day relative volume is 0.71

    Price Performance

    Price Most recent change

    +4.07%
    SNDX price was up +4.07% on Sep 11, 2025

    Price YTD change

    +23.83%
    SNDX price is up +23.83% since January 1st

    Price 1-year change

    -10.64%
    SNDX price is down -10.64% year-on-year

    Price 3-year change

    -33.37%
    SNDX price is down -33.37% over the past 3 years

    Price Range

    Price All-time high

    $29.86
    SNDX price is currently -45.18% below its historical high of $29.86

    Price 3-year low

    $8.58
    SNDX price is currently +90.79% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $1.41B
    SNDX market capitalization is $1.41 billion

    Market cap 3-year change

    +1.46%
    SNDX market capitalization is up +1.46% over the past 3 years

    Market cap All-time high

    $2.11B
    SNDX market capitalization is currently -33.15% below its historical high of $2.11 billion

    Market cap sector rank

    76.55%
    SNDX market capitalization is higher than 76.55% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +1.23%
    SNDX shares outstanding is up +1.23% year-on-year

    Shares Outstanding 3-Year Change

    +52.29%
    SNDX shares outstanding is up +52.29% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    1.19
    SNDX beta is 1.19

    200-day SMA

    $12.84
    SNDX price is currently +27.53% above its 200-day simple moving average

    50-day SMA

    $12.62
    SNDX price is currently +29.71% above its 50-day simple moving average

    RSI

    64.25
    SNDX 14-day relative strength index is 64.25

    Volume

    0.71
    SNDX 30-day relative volume is 0.71

    ATR

    $0.80
    SNDX average true range is $0.80

    10-day Historical Volatility

    44.57%
    SNDX 10-day historical volatility is 44.57%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $23.68M
    SNDX annual revenue is $23.68 million

    Revenue Analysts estimate

    $169.79M
    SNDX annual revenue is currently -86.05% lower than the consensus analysts' forecast

    Revenue 1-year change

    +100%
    SNDX annual revenue is up +100% year-on-year

    Revenue Sector rank

    53.87%
    SNDX annual revenue is higher than 53.87% of companies in Healthcare sector

    EPS

    EPS

    -$3.72
    SNDX annual earnings per share is -$3.72

    EPS Analysts estimate

    -$3.08
    SNDX annual earnings per share is currently +20.70% higher than the consensus analysts' forecast

    EPS 1-year change

    -24.83%
    SNDX annual earnings per share is down -24.83% year-on-year

    EPS Sector rank

    24.39%
    SNDX annual earnings per share is higher than 24.39% of companies in Healthcare sector

    Profit

    Gross profit

    $22.85M
    SNDX annual gross profit is $22.85 million

    Gross margin

    96.48%
    SNDX annual gross profit margin is 96.48%

    Operating profit

    -$339.67M
    SNDX annual operating income is -$339.67 million

    Operating margin

    -1434.43%
    SNDX annual operating profit margin is -1434.43%

    Net income

    -$318.76M
    SNDX annual net profit is -$318.76 million

    Net margin

    -1346.11%
    SNDX annual net profit margin is -1346.11%

    Expenses

    Total expenses

    $342.44M
    SNDX annual total expenses is $342.44 million

    Operating expenses

    $362.52M
    SNDX annual total operating expenses is $362.52 million

    Cost of goods sold

    $834.00K
    SNDX annual cost of goods sold is $834.00 thousand

    Selling, general & administrative expenses

    $0.00
    SNDX annual SGA is $0.00

    Depreciation and amortization

    $8000.00
    SNDX annual depreciation & amortization is $8000.00

    Interest expense

    $0.00
    SNDX annual interest expense is $0.00

    Income tax

    $0.00
    SNDX annual income tax is $0.00

    EBIT & EBITDA

    EBIT

    -$339.67M
    SNDX annual earnings before interest & taxes is -$339.67 million

    EBITDA

    -$339.66M
    SNDX annual EBITDA is -$339.66 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $724.82M
    SNDX annual total assets is $724.82 million

    Non current assets

    $121.76M
    SNDX annual long term assets is $121.76 million

    Current assets

    $603.06M
    SNDX annual total current assets is $603.06 million

    Cash and cash equivalents

    $572.88M
    SNDX annual cash & cash equivalents is $572.88 million

    Accounts receivable

    $7.60M
    SNDX annual accounts receivable is $7.60 million

    Inventory

    $366.00K
    SNDX annual inventory is $366.00 thousand

    Liabilities

    Total liabilities

    $436.69M
    SNDX annual total liabilities is $436.69 million

    Long term liabilities

    $333.14M
    SNDX annual total long term liabilities is $333.14 million

    Current liabilities

    $103.55M
    SNDX annual total current liabilities is $103.55 million

    Accounts payable

    $11.63M
    SNDX annual accounts payable is $11.63 million

    Debt

    Total debt

    $345.74M
    SNDX annual total debt is $345.74 million

    Total debt 1-year change

    +21046.12%
    SNDX annual total debt is up +21046.12% year-on-year

    Long term debt

    $333.14M
    SNDX annual long term debt is $333.14 million

    Short term debt

    $12.60M
    SNDX annual short term debt is $12.60 million

    Equity & Capital

    Shareholders equity

    $288.12M
    SNDX annual stockholders equity is $288.12 million

    Book value

    $288.12M
    SNDX annual book value is $288.12 million

    Retained earnings

    -$1.22B
    SNDX annual retained earnings is -$1.22 billion

    Working capital

    $499.51M
    SNDX annual working capital is $499.51 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$274.90M
    SNDX annual cash flow from operations is -$274.90 million

    Cash from operations 1-year change

    -71.17%
    SNDX annual cash flow from operations is down -71.17% year-on-year

    Cash from investing

    -$219.78M
    SNDX annual cash flow from investing activities is -$219.78 million

    Cash from investing 1-year change

    -286.87%
    SNDX annual cash flow from investing activities is down -286.87% year-on-year

    Cash from financing

    $353.37M
    SNDX annual cash flow from financing activities is $353.37 million

    Cash from financing 1-year change

    +33.78%
    SNDX annual cash flow from financing activities is up +33.78% year-on-year

    CAPEX

    CAPEX

    $0.00
    SNDX annual capital expenditures is $0.00

    CAPEX 1-year change

    0%
    SNDX annual capital expenditures has remained unchanged year-on-year

    Free Cash Flow

    Free cash flow

    -$274.90M
    SNDX annual free cash flow is -$274.90 million

    Free cash flow 1-year change

    -71.17%
    SNDX annual free cash flow is down -71.17% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    96.48%
    SNDX annual gross profit margin is 96.48%

    Operating margin

    -1434.43%
    SNDX annual operating profit margin is -1434.43%

    Net margin

    -1346.11%
    SNDX annual net profit margin is -1346.11%

    ROA & ROE

    ROA

    -47.66%
    SNDX annual return on assets is -47.66%

    ROE

    -75.69%
    SNDX annual return on equity is -75.69%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    SNDX price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    SNDX price to earnings ratio is unknown

    PB Ratio

    PB ratio

    8.96
    SNDX price to book ratio is 8.96

    PB ratio Sector rank

    87.36%
    SNDX price to book ratio is higher than 87.36% of companies in Healthcare sector

    PS Ratio

    PS ratio

    18.04
    SNDX price to sales ratio is 18.04

    PS ratio Sector rank

    79.53%
    SNDX price to sales ratio is higher than 79.53% of companies in Healthcare sector

    Enterprise value

    Enterprise value

    $1.30B
    SNDX enterprise value is $1.30 billion

    Enterprise value Sector rank

    76.08%
    SNDX enterprise value is higher than 76.08% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -4.14
    SNDX EV/EBITDA is -4.14

    EV/EBITDA Sector rank

    25.87%
    SNDX EV/EBITDA is higher than 25.87% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    5.82
    SNDX annual current ratio is 5.82

    Quick ratio

    5.82
    SNDX annual quick ratio is 5.82

    Leverage

    Debt to equity

    1.20
    SNDX annual debt to equity ratio is 1.20

    Interest coverage ratio

    -
    SNDX annual interest coverage ratio value is unknown

    Risk & Stability

    Piotroski F-Score

    3
    SNDX piotroski f-score is 3

    Altman Z-Score

    -1.11
    SNDX altman z-score is -1.11

    Analyst ratings

    Recent major analysts updates

    Sep 5, 25 Goldman Sachs
    Buy
    Sep 4, 25 Guggenheim
    Buy
    Aug 5, 25 Citigroup
    Buy
    Aug 5, 25 BTIG
    Buy
    Jul 15, 25 UBS
    Buy
    Jul 10, 25 Goldman Sachs
    Buy
    May 6, 25 Scotiabank
    Sector Perform
    May 6, 25 Guggenheim
    Buy
    Mar 20, 25 JP Morgan
    Overweight
    Mar 4, 25 JP Morgan
    Overweight

    Institutional Ownership

    Screeners with SNDX included

    Growing Shares Outstanding
    US stocks
    Stocks with high beta
    Best performing stocks last month
    Most recommended stocks
    Best performing stocks last 3 months
    NASDAQ Dividend Calendar
    Stocks above SMA 50
    Stocks below analysts price target
    Healthcare sector
    • What is the ticker symbol for Syndax Pharmaceuticals, Inc.?
    • Does Syndax Pharmaceuticals, Inc. pay dividends?
    • What sector is Syndax Pharmaceuticals, Inc. in?
    • What industry is Syndax Pharmaceuticals, Inc. in?
    • What country is Syndax Pharmaceuticals, Inc. based in?
    • When did Syndax Pharmaceuticals, Inc. go public?
    • Is Syndax Pharmaceuticals, Inc. in the S&P 500?
    • Is Syndax Pharmaceuticals, Inc. in the NASDAQ 100?
    • Is Syndax Pharmaceuticals, Inc. in the Dow Jones?
    • When was Syndax Pharmaceuticals, Inc.'s last earnings report?
    • When does Syndax Pharmaceuticals, Inc. report earnings?

    What is the ticker symbol for Syndax Pharmaceuticals, Inc.?

    The ticker symbol for Syndax Pharmaceuticals, Inc. is NASDAQ:SNDX

    Does Syndax Pharmaceuticals, Inc. pay dividends?

    No, Syndax Pharmaceuticals, Inc. does not pay dividends

    What sector is Syndax Pharmaceuticals, Inc. in?

    Syndax Pharmaceuticals, Inc. is in the Healthcare sector

    What industry is Syndax Pharmaceuticals, Inc. in?

    Syndax Pharmaceuticals, Inc. is in the Biotechnology industry

    What country is Syndax Pharmaceuticals, Inc. based in?

    Syndax Pharmaceuticals, Inc. is headquartered in United States

    When did Syndax Pharmaceuticals, Inc. go public?

    Syndax Pharmaceuticals, Inc.'s initial public offering (IPO) was on March 2, 2016

    Is Syndax Pharmaceuticals, Inc. in the S&P 500?

    No, Syndax Pharmaceuticals, Inc. is not included in the S&P 500 index

    Is Syndax Pharmaceuticals, Inc. in the NASDAQ 100?

    No, Syndax Pharmaceuticals, Inc. is not included in the NASDAQ 100 index

    Is Syndax Pharmaceuticals, Inc. in the Dow Jones?

    No, Syndax Pharmaceuticals, Inc. is not included in the Dow Jones index

    When was Syndax Pharmaceuticals, Inc.'s last earnings report?

    Syndax Pharmaceuticals, Inc.'s most recent earnings report was on August 4, 2025

    When does Syndax Pharmaceuticals, Inc. report earnings?

    The next expected earnings date for Syndax Pharmaceuticals, Inc. is November 5, 2025
    On this page